Objective: To report a rare case of upper airway obstruction from multiple pharyngeal masses due to nasopharyngeal tuberculosis in a 22-year-old male.
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We describe an unusual case of a patient with nasopharyngeal tuberculosis presenting with upper airway obstruction.
CASE REPORT
A twenty-two-year-old male with a four-year history of gradually enlarging bilateral neck masses, hyponasal speech, progressive dyspnea and dysphagia presented with impending upper airway obstruction. The patient was initially seen with sternal and intercostal retractions, stridor and tachypnea. He denied any epistaxis, ear symptoms or chronic cough, had an eleven-pack-year smoking history and lived with his father who had been previously diagnosed with and inadequately treated for pulmonary tuberculosis.
Initial endoscopy revealed midline masses bulging from the midline posterior nasopharyngeal and hypopharyngeal walls, approximately 2cm x 1cm and 2cm x 2cm in size, respectively. There were wellcircumscribed, matted, doughy, movable, bilateral level II and III cervical lymph nodes measuring 5cm x 4cm x 1cm on the right and 2.7cm x 3.6cm x 1cm on the left.
Hematology showed only slight anemia with a normal white blood cell count. Chest radiographs revealed homogenous opacification of the left upper lung field and fibrous infiltrates in both lower lung fields. Computed tomography of the paranasal sinuses and neck showed a retropharyngeal mass, mucosal thickening in the nasopharynx, and multiple cervical lymphadenopathies. (Figure 1 )
Progression of dyspnea necessitated a tracheotomy and hypopharyngeal aspiration-biopsy that yielded 14 mL of serosanguinous fluid with resolution of dyspnea and dysphagia.
A nasopharyngeal biopsy revealed chronic granulomatous inflammation with caseation necrosis and Langhans giant cells compatible with a tuberculous etiology of the nasopharyngeal mass. Cytologic examination of the hypopharyngeal aspirate showed chronic inflammation with mild dysplasia. Acid fast staining was negative. Sputum culture and sensitivity with acid fast staining showed no growth and no acid fast bacilli. Purified protein derivative testing was positive with fifteen millimetres skin induration.
The nasopharyngeal and hypopharyngeal masses and lymphadenopathies resolved with a six-month regimen of antituberculosis medications consisting of isoniazid, rifampicin, pyrazinamide and ethambutol for two months followed by isoniazid and rifampicin for four months. (Figure 2 ) DISCUSSION Nasopharyngeal tuberculosis is an uncommon entity and comprises only 0.12% of all tuberculosis. 3 Other upper respiratory tract sites that may have tuberculous involvement are the tonsils, hypopharynx, tongue, soft palate and the larynx. 6 Generally, the upper respiratory tract is thought to be resistant to tuberculosis because saliva has an inhibitory effect on tubercle bacilli. The thickness of the protective epithelial covering and antagonism of the striated musculature to bacteria also defend against tuberculosis whose pathophysiology usually requires a disruption of local mucosa leading to implantation from other foci in the body (e.g. inoculation from sputum). This may explain the localization of ulcers in the posterior part of the roof and the posterior wall of the nasopharynx. Although difficult to confirm, hematogenous spread from pulmonary tuberculosis is also considered as another means of infection, as is activation of dormant acid fast bacilli 
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PhiliPPine Journal of otolaryngology-head and neck Surgery in adenoids during childhood. 5 The disease may occur as a primary infection, without involvement of any other system, or as a secondary infection, with simultaneous pulmonary involvement as in our case.
The most common symptom of nasopharyngeal involvement is cervical lymphadenopathy, comprising about 70%. 7 Other symptoms include chronic cough, epistaxis, nasal obstruction, tinnitus, hearing loss, otitis media and even cranial nerve involvement like diplopia. 5 Varying clinical presentations make diagnosis difficult. In our case the patient did present with a nasopharyngeal mass and cervical lymphadenopathy, but he also experienced upper airway obstruction due to a hypopharyngeal mass, probably resulting from retropharyngeal lymph node involvement.
The common differential diagnoses include nasopharyngeal carcinoma, Wegener's granulomatous, sarcoidosis, syphilis, leprosy, lymphoma and fungal infection. 9 The diagnosis of nasopharyngeal tuberculosis is best done by biopsy to differentiate it from other nasopharyngeal masses. Histopathologic findings in tuberculosis usually include granulomatous inflammation composed of epitheloid cells and Langhan's giant cells with or without caseation. Demonstration of acid fast bacilli or a positive culture for Mycobacterium tuberculosis gives a definite diagnosis, but few specimens demonstrate acid fast bacilli with the majority yielding negative results. 10 Diagnostic imaging is inaccurate in confirming the diagnosis. The gold standard for the diagnosis of nasopharyngeal tuberculosis remains to be tissue biopsy. Treatment for extrapulmonary and pulmonary tuberculosis is the same unless organisms are known and strongly suspected to be resistant to the first line drugs, or if the patient is diagnosed with tuberculous meningitis. 2 In our patient, a sixmonth regimen consisting of isoniazid, rifampicin, pyrazinamide and ethambutol for two months as the initial phase followed by isoniazid and rifampicin for four months as the continuation phase was advocated.
The resolution of the nasopharyngeal mass and cervical lymphadenopathies after completion of the anti-tuberculous medications, further confirms our diagnosis of nasopharyngeal tuberculosis. Tuberculosis should not be overlooked in the differential diagnoses of nasopharyngeal masses because of the difference in its management, and swift and adequate cure, compared to other nasopharyngeal pathologies. 
